bioXXmed AG (FRA:T5O)
Germany · Delayed Price · Currency is EUR 1.010
-0.020 (-1.94%)
Last updated: Sep 14, 2026, 1:25 PM CET
bioXXmed AG Market Cap
bioXXmed AG has a market cap or net worth of €274.58 thousand as of September 15, 2026. Its market cap has increased by 61.96% in one year.
Market Cap
274.58K
Enterprise Value
455.91K
Revenue
16.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.01
ChartMarket Cap Chart
Since December 13, 2006, bioXXmed AG's market cap has decreased from 16.12M to 274.58K, a decrease of -98.30%. That is a compound annual growth rate of -18.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 274.58K | 818.19% |
| Dec 30, 2025 | 29.91K | -95.56% |
| Dec 30, 2024 | 673.01K | -88.20% |
| Dec 30, 2022 | 5.70M | -69.02% |
| Dec 30, 2021 | 18.41M | -70.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 84.00M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 29.39M |
| Vidac Pharma Holding | 20.55M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| MagForce AG | 91.72K |